Mitsui & Co., Ltd.:企業のM&A・事業提携・投資動向

◆英語タイトル:Mitsui & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1521
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:148
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:一般ビジネス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Mitsui & Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Mitsui & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Mitsui & Co., Ltd. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Mitsui & Co., Ltd.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Mitsui & Co., Ltd.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Mitsui & Co., Ltd.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Mitsui & Co., Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Mitsui & Co., Ltd.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Mitsui & Co., Ltd.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 64
Corporate Venturing – Overview 64
Corporate Venturing – Deal reports 65
PARTNERSHIP 101
Partnership – Overview 101
Partnership – Deal reports 102
DIVESTMENTS 109
Divestments – Overview 109
Divestments – Deal reports 110
APPENDIX 138
Contact Us 138
About MarketLine Financial Deals Database 138
Deal Definition and Methodology 140
About MarketLine 147

List of Tables
Table 1: Mitsui & Co. M&A volume and value trend (2014-YTD2018)
Table 2: Mitsui & Co. M&A activity by geography (2014-YTD2018)
Table 3: Mitsui & Co. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Mitsui & Co. corporate venturing by geography (2014-YTD2018)
Table 5: Mitsui & Co. partnership volume and value trend (2014-YTD2018)
Table 6: Mitsui & Co. partnership trend by key deal type (2014-YTD2018)
Table 7: Mitsui & Co. divestments volume and value trend (2014-YTD2018)
Table 8: Mitsui & Co. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Mitsui & Co. M&A volume and value trend (2014-YTD2018)
Figure 2: Mitsui & Co. M&A activity by geography (2014-YTD2018)
Figure 3: Mitsui & Co. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Mitsui & Co. corporate venturing by geography (2014-YTD2018)
Figure 5: Mitsui & Co. partnership volume and value trend (2014-YTD2018)
Figure 6: Mitsui & Co. partnership trend by key deal type (2014-YTD2018)
Figure 7: Mitsui & Co. divestments volume and value trend (2014-YTD2018)
Figure 8: Mitsui & Co. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Mitsui & Co., Ltd.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arthrex Inc:企業の戦略的SWOT分析
    Arthrex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Emmaus Life Sciences Inc (EMMA):企業の財務・戦略的SWOT分析
    Emmaus Life Sciences Inc (EMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Mediware Information Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Broadspectrum (Australia) Pty Ltd:企業の戦略的SWOT分析
    Broadspectrum (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • AGCO Corporation (AGCO):企業の財務・戦略的SWOT分析
    AGCO Corporation (AGCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Yumanity Therapeutics Inc (YMTX):企業の財務・戦略的SWOT分析
    Yumanity Therapeutics Inc (YMTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Antiva Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Antiva Biosciences Inc (Antiva) formerly Hera Therapeutics Inc, is a clinical stage bio-pharmaceutical company focused on the development of novel medicines for the treatment of diseases caused by human papillomavirus (HPV) infection. Its lead product candidate ABI-1968, is a double prodrug …
  • NeuroDerm Ltd (NDRM)-医療機器分野:企業M&A・提携分析
    Summary NeuroDerm Ltd (NeuroDerm) is a clinical stage pharmaceutical company that focuses on the development of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s levodopa/carbidopa (LD/CD) …
  • MyCartis NV-医療機器分野:企業M&A・提携分析
    Summary MyCartis NV (MyCartis), formerly Pronota NV is a biomarker analysis solution provider. The company develops multiplexed biomarker solutions through evalution and bio assays technology. It uses technologies such as barcoded microparticles, microfluidic assay cartridges and evalution instrumen …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • Antaros Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Antaros Medical AB (Antaros Medical) is a drug development and technology company that offers innovative MRI and PET imaging techniques for decision making in clinical drug development. The company's services include small- to medium-sized studies, decision-making in Phase 1b and Phase 2 tri …
  • Genesis Energy LP (GEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genesis Energy LP (Genesis) is a midstream oil and gas company. The company provides services such as offshore pipeline transportation, refinery services, marine transportation, and onshore facilities and transportation. It purchases, transports, stores, blends, and markets crude oil and ref …
  • Bharat Dynamics Limited:企業の戦略・SWOT・財務分析
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Intelligent Energy Ltd:電力:M&Aディール及び事業提携情報
    Summary Intelligent Energy Ltd (Intelligent Energy), a subsidiary of Intelligent Energy Holdings plc, is a diversified company that offers fuel cell stack technology. The company operates through its divisions such as stationary power, automotive and consumer electronics. Its consumer electronics di …
  • Linklaters Llp
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Gecina SA:企業のM&A・事業提携・投資動向
    Gecina SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gecina SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • DiaCarta Inc:医療機器:M&Aディール及び事業提携情報
    Summary DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection ki …
  • Feldan Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and research products. Its genome editing product includes recombinant …
  • Antibe Therapeutics Inc (ATE):企業の財務・戦略的SWOT分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • Alabama Municipal Electric Authority:企業の戦略的SWOT分析
    Alabama Municipal Electric Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆